Cargando…
Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2
Autores principales: | Xiu, Huiqing, Gong, Jiali, Huang, Tiancha, Peng, Yanmei, Bai, Songjie, Xiong, Guirun, Zhang, Shufang, Huang, Huaqiong, Cai, Zhijian, Zhang, Gensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165339/ https://www.ncbi.nlm.nih.gov/pubmed/34059790 http://dx.doi.org/10.1038/s41423-021-00698-5 |
Ejemplares similares
-
The effect of renin–angiotensin–aldosterone system inhibitors in patients with hypertension and COVID-19: A meta-analysis of randomized controlled trials and propensity score-matched studies
por: Zhang, Kai, et al.
Publicado: (2022) -
Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
por: Yang, Jie, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013) -
Gp350-anchored extracellular vesicles: promising vehicles for delivering therapeutic drugs of B cell malignancies
por: Xiu, Huiqing, et al.
Publicado: (2022) -
Clinical characteristics of and risk factors for secondary bloodstream infection after pneumonia among patients infected with methicillin-resistant Staphylococcus aureus
por: Huang, Fangfang, et al.
Publicado: (2022)